Investigation and control of an outbreak of enterobacter aerogenes bloodstream infection in a neonatal intensive care unit in Fiji

Infection Control and Hospital Epidemiology

Volumn 30, Issue 8, 2009, Pages 797-800

  Narayan, Swastika A ^a   Kool, Jacob L ^b   Vakololoma, Miriama ^a   Steer, Andrew C ^d   Mejia, Amelita ^a   Drake, Anne ^c   Jenney, Adam ^a,d   Turton, Jane F ^e   Kado, Joseph ^a   Tikoduadua, Lisi ^a  

^a Ministry of Health and Medical Services   (Fiji)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c FIJI SCHOOL OF MEDICINE   (Fiji)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; SODIUM CHLORIDE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CLINICAL ARTICLE; CLINICAL PRACTICE; ENTEROBACTER AEROGENES; EPIDEMIC; FEMALE; FIJI; HEALTH CARE POLICY; HUMAN; HYGIENE; INFECTION CONTROL; MALE; NEWBORN; NEWBORN INTENSIVE CARE; NONHUMAN; PRACTICE GUIDELINE; PULSED FIELD GEL ELECTROPHORESIS;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CROSS INFECTION; DRUG CONTAMINATION; ENTEROBACTER AEROGENES; ENTEROBACTERIACEAE INFECTIONS; EQUIPMENT CONTAMINATION; FEMALE; FIJI; HANDWASHING; HUMANS; INFANT; INFANT, NEWBORN; INFECTION CONTROL; INTENSIVE CARE UNITS, NEONATAL; MALE; REHYDRATION SOLUTIONS; RISK FACTORS; SEPSIS; TREATMENT OUTCOME;

EID: 67651123027     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/598240     Document Type: Article

References (10)

1. Sohn AH, Garrett DO, Sinkowitz-Cochran RL, et al. Prevalence of nosocomial infections in neonatal intensive care unit patients: results from the first national point-prevalence survey. J Pediatr 2001; 139:821-827.
2. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in pediatric intensive care units in the United States. Pediatrics 1999; 103: 39-45.
3. Polak JD, Ringler N, Daugherty B. Unit based procedures: impact on the incidence of nosocomial infections in the newborn intensive care unit. Newborn Infant Nurs Rev 2004; 4:38-45.
4. Couto RC, Pedrosa TM, Tofani Cde P, Pedroso ER. Risk factors for nosocomial infection in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2006; 27:571-575.
5. Elward AM, McGann KA. Steps to reduce nosocomial infections in children. Infect Med 2002; 19:414-424.
6. Fraser SL, Arnett M, Sinave CP. Enterobacter infections. eMedicine. Updated August 28, 2008. Available at: http://www.emedicine.com/ med/topic678.htm. Accessed August 22, 2007.
7. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: 17th Informational Supplement. Wayne, PA: CLSI; 2007:M100-S17.
8. Turton JF, Kaufmann ME, Mustafa N, Kawa S, Clode FE, Pitt TL. Molecular comparison of isolates of Burkholderia multivorans from patients with cystic fibrosis in the United Kingdom. J Clin Microbiol 2003; 41: 5750-5754.
9. Fok TF, Lee CH, Wong EM, et al. Risk factors for Enterobacter septicemia in a neonatal unit: case control study. Clin Infect Dis 1998; 27:1204-1209.
10. Vergnano S, Sharland M, Kazembe P, Mwansambo C, Heath PT.Neonatal sepsis: an international perspective. Arch Dis Child Fetal Neonatal Ed 2005; 90:F220-224.